New drug cocktail aims to boost lymphoma remission
Disease control
Not yet recruiting
This study tests whether adding zanubrutinib to the standard R2 regimen (rituximab and lenalidomide) improves outcomes for adults with newly diagnosed follicular lymphoma. About 100 participants will be randomly assigned to receive either the new ZR2 combo or standard R2, followe…
Phase: PHASE2 • Sponsor: KeshuZhou • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC